Publication - Research and analysis
Cancer strategy 2023-2033 and cancer action plan 2023-2026: monitoring and evaluation framework - August 2023
This outlines our intent to monitor and evaluate the Cancer Strategy for Scotland 2023-2033 and Cancer Action Plan 2023-2026. It sets out a strategic, evidence-based and outcomes-focused approach to assess progress towards the vision of improved survival and excellent, equitably accessible care.
Appendix 1: Advisory group members
The following table lists the advisory group members who contributed their expertise to guide our approach to monitoring and evaluating the Cancer Strategy.
| Name | Role | Organisation |
|---|---|---|
| Gregor Mcnie | Unit Head, Cancer and Rehabilitation Unit (Chair) | SG Healthcare Planning & Quality |
| Rachel Anderson | Principal Research Officer, Population Health | SG Health & Social Care Analysis |
| Gregor Boyd | Unit Head, Healthcare and Workforce | SG Health & Social Care Analysis |
| Emma Dunlop | Research Associate, Institute of Pharmacy & Biomedical Sciences | University of Strathclyde |
| Samantha Harrison | Head of Strategic Evidence & International Cancer Benchmarking Partnership Research Lead | Cancer Research UK |
| Aisha Macgregor | Senior Social Researcher, Whole Systems Intelligence | SG Whole Systems Intelligence Analysis |
| Nicola McCloskey-Sellar | Regional Manager, South East Scotland Cancer Network | South East Scotland Cancer Network |
| David Morrison | Director of Scottish Cancer Registry | Public Health Scotland |
| Paul Nairn | Regional Planning Manager | NHS Highland |
| Sasia Pryor | Cancer Service Manager & Chair of Cancer Managers Forum | NHS Grampian |
Contact
Email: socialresearch@gov.scot
There is a problem
Thanks for your feedback